Brief: Bone Therapeutics To Develop And Commercialize ALLOB With Link Health And Pregene
Oct 5 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* BONE THERAPEUTICS GRANTS EXCLUSIVE LICENSE TO LINK HEALTH
AND
PREGENE FOR DEVELOPMENT AND COMMERCIALIZATION OF ALLOB IN
GREATER CHINA AND A NUMBER OF OTHER MAJOR ASIAN COUNTRIES
* TERMS INCLUDE EUR 55 MILLION IN TOTAL UPFRONT AND
MILESTONE
PAYMENTS WITH EUR 10 MILLION EXPECTED IN NEXT 24 MONTHS AS WELL
AS TIERED DOUBLE-DIGIT ROYALTIES ON NET SALES
Source text for Eikon: ID:nGNE578018
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd